Unraveling Hereditary Cancer With The Rising Demand For Hereditary Cancer Testing: Transformative Forces Shaping the Hereditary Cancer Testing Market Landscape in 2025

Use code ONLINE20 to get 20% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

What Will the Hereditary Cancer Testing Industry Market Size Be by 2025?
The market encompassing hereditary cancer testing has exhibited robust expansion throughout the recent past, projecting an increase from its value of $4.32 billion in 2024 to reach $4.75 billion for the subsequent year, reflecting a consistent annual growth rate approximating 10.0%. This upward momentum observed during the historical timeframe is primarily fueled by several key factors, including the increasing prevalence of hereditary cancer cases, the broader availability of genetic counseling services, supportive governmental efforts aimed at cancer prevention, enhancements in insurance provisions, a deeper comprehension of how genes and environmental factors interact, alongside the significant contributions of patient advocacy organizations and various support networks.

What's the Long-Term Growth Forecast for the Hereditary Cancer Testing Market Size Through 2029?
Anticipating a swift expansion, the market dedicated to hereditary cancer testing is projected to achieve a valuation of $7.27 billion by 2029, propelled by a Compound Annual Growth Rate (CAGR) of 11.3% across the upcoming years. This considerable upsurge throughout the projection timeframe stems from several key factors, including the broader adoption of targeted therapies, notable developments in the field of precision medicine, an increase in testing offered directly to consumers, various worldwide health campaigns, and significant strides made in bioinformatics. Furthermore, the coming period will be characterized by several important developments, such as innovations in genetic sequencing methods, the integration of telemedicine alongside remote support for genetic counseling, a deeper focus on personalized treatment pathways through precision medicine, the refinement of models used for assessing cancer risk, and ongoing discussions surrounding the ethical and legal facets of this domain.

View the full report here:
https://www.thebusinessresearchcompany.com/report/hereditary-cancer-testing-global-market-report

What Are the Key Growth Drivers Fueling the Hereditary Cancer Testing Market Expansion?
The expanding incidence of cancers passed down through families is projected to fuel the market for hereditary cancer diagnostics. Since hereditary cancer syndromes stem from inherited alterations in certain genes transmitted across generations, these specialized tests are essential for identifying specific, heritable mutations linked to disease, thus facilitating thorough evaluations of an individual's cancer risk. As an illustration, data from a June 2022 BioMed Central publication analyzing hereditary cancer in clinical settings indicated that roughly ten percent of individuals diagnosed with pancreatic cancer possess an underlying genetic predisposition, underscoring how the rising occurrence of such inherited cancers propels the expansion of the hereditary cancer testing sector.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=8121&type=smp

What Are the Key Trends Driving Hereditary Cancer Testing Market Growth?
A significant movement within the market for hereditary cancer testing revolves around advancements in technology, with major participants prioritizing these innovations as a means to maintain their competitive standing. To illustrate this focus, in March of 2022, Myriad Genetics, an American firm specializing in genetic testing and precision medicine, introduced a new genetic test incorporating a Polygenic Breast Cancer Risk Assessment Score applicable across all ancestral groups. Specifically, their MyRisk Hereditary Cancer test, which features the RiskScore, now provides a tailored evaluation of breast cancer risk to any woman without a prior diagnosis, irrespective of her ethnic background.

How Is the Hereditary Cancer Testing Market Segmented?
The hereditary cancer testingmarket covered in this report is segmented -

1) By Test Type: Multi Panel Test; Single-Site Genetic Test
2) By Indication: Breast Cancer; Ovarian Cancer; Colorectal Cancer; Other Indications
3) By End user: Hospital; Clinics; Diagnostic Centers

Subsegments:
1) By Multi Panel Test: Comprehensive Genetic Panels; Targeted Gene Panels
2) By Single-Site Genetic Test: Specific Gene Testing; Familial Mutation Testing

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=8121&type=smp

Which Companies Are Leading the Charge in Hereditary Cancer Testing Market Innovation?
Major companies operating in the hereditary cancer testing market are Centogene NV, Ambry Genetics Inc., Myriad Genetics Inc., NeoGenomics Laboratories Inc., Quest Diagnostics, PreventionGenetics, Fulgent Genetics Inc., Invitae Corporation, Medical Diagnostic Laboratories LLC, Natera Inc., Color Health Inc., CooperSurgical Inc., OPKO Health Inc., Illumina Inc., Laboratory Corporation of America Holdings, Pathway Genomics Corporation, Strand Life Sciences Private Limited, Progenity Inc., Myogenes Ltd., Associated Regional and University Pathologists Inc., 4baseCare, Biocartis Group NV, F. Hoffmann-La Roche AG, Medgenome Pvt. Ltd., Abbott Laboratories, Agilent Technologies Inc., Bio-Rad Laboratories Inc., Thermo Fisher Scientific Inc., Oxford Nanopore Technologies PLC, PerkinElmer Inc.

Which Regions Are Leading the Global Hereditary Cancer Testing Market in Revenue?
North America was the largest region in the hereditary cancer testing market in 2024. The regions covered in the hereditary cancer testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=8121

This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Reach out to us:
The Business Research Company: https://www.thebusinessresearchcompany.com/,
Americas +1 310-496-7795,
Europe +44 7882 955267,
Asia & Others +44 7882 955267 & +91 8897263534,
Email us at info@tbrc.info.

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Learn More About The Business Research Company
With over 17500+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.